Healthcare Resource Utilization (HCRU) in Patients (pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Treated in the Connect® MDS/AML Disease Registry

被引：0
|
作者：
Mukherjee, Sudipto [1 ]
Abedi, Mehrdad [2 ]
Erba, Harry P. [3 ]
Pollyea, Daniel A. [4 ]
Roboz, Gail J. [5 ]
Thompson, Michael A. [6 ]
Louis, Chrystal U. [7 ]
Flick, E. Dawn [8 ]
Nifenecker, Melissa [7 ]
Kiselev, Pavel [7 ]
Swern, Arlene S. [7 ]
Cogle, Christopher R. [9 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Univ Colorado, Denver, CO 80202 USA
[5] Weill Cornell Med Coll, New York, NY USA
[6] Advocate Aurora Hlth, Aurora Res Inst, Milwaukee, WI USA
[7] Celgene Corp, Summit, NJ USA
[8] Celgene Corp, San Francisco, CA USA
[9] Univ Florida, Gainesville, FL USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-112935
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4736
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Post-Remission Treatment (Tx) Patterns for Patients (Pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) in the Connect® MDS/AML Disease Registry
    Roboz, Gail J.
    Cogle, Christopher R.
    Pollyea, Daniel A.
    Abedi, Mehrdad
    Thompson, Michael A.
    Nifenecker, Melissa
    Flick, E. Dawn
    Kiselev, Pavel
    Louis, Chrystal U.
    Little, Michelle
    Erba, Harry P.
    BLOOD, 2020, 136
  • [2] MOLECULAR GENETIC TESTING PATTERNS FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) ENROLLED IN THE CONNECT® MDS/AML DISEASE REGISTRY
    Pollyea, D.
    George, T.
    Foucar, K.
    Erba, H.
    Thompson, M.
    Roboz, G.
    Landau, D.
    Pagel, J.
    Seiter, K.
    Cogle, C.
    Nifenecker, M.
    Swern, A.
    Kiselev, P.
    Sugrue, M.
    HAEMATOLOGICA, 2017, 102 : 379 - 379
  • [3] Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry
    Pollyea, Daniel A.
    George, Tracy I.
    Abedi, Mehrdad
    Bejar, Rafael
    Cogle, Christopher R.
    Foucar, Kathryn
    Garcia-Manero, Guillermo
    Grinblatt, David L.
    Komrokji, Rami S.
    Maciejewski, Jaroslaw P.
    Revicki, Dennis A.
    Roboz, Gail J.
    Savona, Michael R.
    Scott, Bart L.
    Sekeres, Mikkael A.
    Thompson, Michael A.
    Kurtin, Sandra E.
    Louis, Chrystal U.
    Nifenecker, Melissa
    Flick, E. Dawn
    Swern, Arlene S.
    Kiselev, Pavel
    Steensma, David P.
    Erba, Harry P.
    EJHAEM, 2020, 1 (01): : 58 - 68
  • [4] CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY
    Steensma, D.
    Abedi, M.
    Bejar, R.
    Cogle, C.
    Foucar, K.
    Garcia-Manero, G.
    George, T.
    Grinblatt, D.
    Komrokji, R.
    Maciejewski, J.
    Pollyea, D.
    Roboz, G.
    Savona, M.
    Scott, B.
    Sekeres, M.
    Thompson, M.
    Sugrue, M.
    Swern, A.
    Nifenecker, M.
    Erba, H.
    LEUKEMIA RESEARCH, 2015, 39 : S124 - S124
  • [5] Molecular genetic testing patterns for patients with newly diagnosed acute myeloid leukemia (AML) enrolled in the CONNECT MDS/AML disease registry.
    Pollyea, Daniel Aaron
    George, Tracy
    Foucar, Kathryn M.
    Erba, Harry Paul
    Thompson, Michael A.
    Abedi, Mehrdad
    Roboz, Galli J.
    Landau, Danny
    Pagel, John M.
    Seiter, Karen
    Cogle, Christopher R.
    Nifenecker, Melissa
    Swern, Arlene S.
    Kiselev, Pavel
    Sugrue, Mary M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Examining Healthcare Resource Utilization (HCRU) and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia (AML)
    Tabah, Ashley
    Knoth, Russell
    Huggar, David
    Copher, Ronda M.
    Cao, Zhun
    Lipkin, Craig
    Leblanc, Thomas W.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S181 - S181
  • [7] Connect MDS and AML: The myelodysplastie syndromes (MDS) and acute myeloid leukemia (AML) disease registry.
    Steensma, David P.
    Abedi, Mehrdad
    Attar, Eyal C.
    Bejar, Rafael
    Cogle, Christopher R.
    Garcia-Manero, Guillermo
    Grinblatt, David L.
    Ma, Xlaomei
    Maciejowski, Jaroslaw P.
    Pollyea, Daniel Aaron
    Roboz, Gail J.
    Savona, Michael
    Scott, Bart L.
    Sekenos, Mikkael A.
    Thompson, Michael A.
    Zernovak, Oleg
    Sugrue, Mary M.
    Swern, Arlene S.
    Nifonecker, Melissa
    Erba, Harry Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Factors influencing first-line therapy of acute myeloid leukemia (AML) patients (pts) in the Connect MDS/AML Disease Registry.
    Cogle, Christopher R.
    Pollyea, Daniel Aaron
    Abedi, Mehrdad
    Thompson, Michael A.
    Roboz, Gail J.
    Louis, Chrystal Ursula
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Molecular diagnostic testing patterns in patients (pts) with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) in the Connect MDS/AML Registry.
    George, Tracy
    Patel, Jay L.
    Abedi, Mehrdad
    Cogle, Christopher R.
    Erba, Harry Paul
    Garcia-Manero, Guillermo
    Grinblatt, David L.
    Kiselev, Pavel
    Komrokji, Rami S.
    Louis, Chrystal Ursula
    Maciejewski, Jaroslaw P.
    Nifenecker, Melissa
    Pollyea, Daniel Aaron
    Roboz, Gail J.
    Savona, Michael R.
    Scott, Bart L.
    Sekeres, Mikkael A.
    Steensma, David P.
    Thompson, Michael A.
    Foucar, Kathryn
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
    Stein, Eytan M.
    Latremouille-Viau, Dominick
    Guerin, Annie
    Shi, Sherry
    Gagnon-Sanschagrin, Patrick
    Bonifacio, Gaetano
    Joseph, George J.
    BLOOD, 2016, 128 (22)
12345